Literature DB >> 6264068

Reductions in blood pressure, heart rate and renal sympathetic nervous discharge after imidazole-4-acetic acid: mediation through central gamma-aminobutyric acid (GABA) receptor stimulation.

M J Antonaccio, D W Snyder.   

Abstract

Intracerebroventricular administration of imidazole-4-acetic acid (IAA) (0.3--10 microgram/kg) significantly reduced mean arterial pressure, heart rate and renal sympathetic nerve discharge in chloralose-anesthetized cats. In contrast, i.v. administration of IAA did not lower arterial pressure or heart rate. This would suggest that the hypotensive and bradycardic effects of IAA were centrally mediated. The cardiovascular effects of IAA were attenuated by the central administration of bicuculline methiodide (15 microgram/kg), a gamma-aminobutyric acid receptor antagonist. Reflex bradycardia evoked during the pressor response to norepinephrine (0.03--1.0 microgram/kg i.v.) was reversed to tachycardia after only the central administration of IAA. The vasoconstrictor response evoked during a 20-sec period of bilateral occlusion of carotid arteries was not altered by IAA. These results suggest that the cardiovascular effects of IAA are mediated through the activation of central gamma-aminobutyric acid receptors, to inhibit sympathetic vasomotor outflow.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6264068

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  3 in total

1.  The interaction between endogenous opioid peptides and GABA in lower brain stem.

Authors:  J H Wu; H Ding; K Yang
Journal:  J Tongji Med Univ       Date:  1987

2.  Pharmacological analysis of the central cardiovascular effects of four GABA analogues.

Authors:  P Bousquet; J Feldman; R Bloch; J Schwartz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-04       Impact factor: 3.000

3.  Involvement of central dopamine receptors in the hypotensive action of pergolide.

Authors:  A L Jadhav; R N Willett; H N Sapru; M F Lokhandwala
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-12       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.